For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Striking Speed and Compliance Balance in Cell Therapy Patient Access
Saturday, September 9, 2023 11:00 AM - 12:00 PM  
337 AB
Session Objectives:
  • What needs to be done to enable speed at the manufacturing and regulatory levels to deliver therapies to patients effectively?
  • Applying standardization and automation into cell therapy processes and where they belong to achieve speed to market and regulatory compliance
  • How to accelerate cell therapies to market while maintaining compliance protocols
  • How collaborative relationships with tool and technology providers enable speed and innovation
  • Dissecting the importance of successful vendor collaboration for cell therapy success
  • How organizations ensure that the work completed in the research phase as it moves to Process Development has a consistent path
  • Understanding the value of replicating at small scale to large scale to move with speed and maintaining regulatory compliance.

SPONSORED BY:
Austin Bigley
Vice President, Research & Development
Indapta Therapeutics
Panelist


Ignacio Nunez
CEO/ Founder
Bioxcl
Panelist


Josh Ludwig
Global Director, Commercial Operations
ScaleReady
Chair


Brent Chesson
Immatics
Panelist


Dara Missan PhD|MT (ASCP)
Development Technologist II
Mayo Clinic - Phoenix
Panelist